🇺🇸 FDA
Drug

dexlansoprazole

Brand: DEXLANSOPRAZOLE

approved

Quick answer

dexlansoprazole (DEXLANSOPRAZOLE), is a pharmaceutical active ingredient, associated with TAKEDA PHARMACEUTICAL CO LTD, with approved status in the US.

Key facts

INN
dexlansoprazole
Brand
DEXLANSOPRAZOLE
Route
ORAL
Formulation
TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE
Originator
TAKEDA PHARMACEUTICAL CO LTD

Related patents

patent

US 9114085

Modified release pharmaceutical compositions of dexlansoprazole

Expires Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 8758818

Oral tablet compositions of dexlansoprazole

Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 8753682

Dual release oral tablet compositions of dexlansoprazole

Expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 8741345

Modified release pharmaceutical compositions of dexlansoprazole

Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 8563034

Dual release oral tablet compositions of dexlansoprazole

Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 8563035

Oral tablet compositions of dexlansoprazole

Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is dexlansoprazole?

dexlansoprazole (DEXLANSOPRAZOLE), is a pharmaceutical active ingredient, associated with TAKEDA PHARMACEUTICAL CO LTD, with approved status in the US.

What is the brand name for dexlansoprazole?

DEXLANSOPRAZOLE is a marketed brand name for dexlansoprazole. Check FDA Drugs@FDA for the current US label holder.